640
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor

, MD PhD, , MD FACP, , MD PhD, , MD PhD, , MD, , MD PhD, , MD & , MD PhD show all

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (16)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.